# Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy

> **NCT07163585** · NA · COMPLETED · sponsor: **RESnTEC, Institute of Research** · enrollment: 102 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Brivaracetam
- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT07163585
- **Lead sponsor:** RESnTEC, Institute of Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2025-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07163585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07163585, "Comparison of Oral Brivaracetam Versus Levetiracetam as Monotherapy in Epilepsy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07163585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*